CervoMed Inc. Common Stock
CRVO •
Sell Open
Signal type
Sell
Status
Open
Open Price
$7.29
Stop Loss
$9.54
Performance
44.58%
Days Open
117
Signal Setup
Signal Type Sell
Status Open
Open Date Dec 19, 2025
Open Price $7.29
Stop Loss $9.54
Timespan Day
Company Profile
Name CervoMed Inc. Common Stock
Ticker CRVO
Market Cap $54.70M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $4.04
List Date Jun 18, 1996
Description
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Website Open Company Website